In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Total revenues | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.4 | 0.1 | 0.0 |
Revenue growth | -100.0% | | | | -100.0% | 640.7% | | |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.4 | 0.1 | 0.0 |
Gross margin | | 100.0% | | | | 100.0% | 100.0% | |
Selling, general and administrative [+] | 41.5 | 49.6 | 13.1 | 10.7 | 11.1 | 2.8 | 1.7 | 9.5 |
General and administrative | | | 13.1 | 10.7 | 11.1 | 2.8 | 1.7 | |
Research and development | 29.0 | 35.0 | 38.8 | 37.2 | 18.5 | 8.2 | 4.3 | 19.4 |
Equity in earnings | | | | | | | | |
Other operating expenses | -70.5 | -40.4 | | | | | | 0.3 |
EBITDA [+] | 0.1 | -43.7 | -51.9 | -47.8 | -29.6 | -10.6 | -5.9 | -29.2 |
EBITDA growth | -100.3% | -15.8% | 8.4% | 61.6% | 179.1% | 79.2% | -79.7% | 35.8% |
EBITDA margin | | -16995.3% | | | | -2650.5% | -10957.4% | |
Depreciation and amortization | 0.1 | 0.3 | 0.3 | 0.5 | 0.4 | 0.3 | 0.0 | 0.1 |
EBIT [+] | 0.0 | -43.9 | -52.2 | -48.4 | -30.0 | -10.9 | -5.9 | -29.3 |
EBIT growth | -100.0% | -15.8% | 7.9% | 61.4% | 173.6% | 84.8% | -79.8% | 35.9% |
EBIT margin | | -17094.6% | | | | -2737.0% | -10968.5% | |
Non-recurring items [+] | | 5.4 | 26.9 | 21.7 | | | | |
Asset impairment | | | 26.9 | 21.7 | | | | |
In-process research & development | | 5.4 | | | | | | |
Interest expense, net [+] | | | 0.1 | 0.0 | 1.2 | 0.5 | 2.6 | -0.1 |
Interest expense | | | 0.1 | | 1.2 | 0.5 | 2.6 | |
Interest income | | | | 0.0 | | | | 0.1 |
Other income (expense), net [+] | -43.0 | -0.3 | 0.9 | 1.5 | -2.3 | 0.1 | -0.5 | 0.5 |
Gain (loss) on debt retirement | | | | | -1.8 | | -0.2 | |
Gain (loss) on foreign currency transactions | | | -0.1 | 0.1 | -0.2 | | | |
Other | | | 0.9 | | -3.5 | -0.3 | -3.1 | 0.5 |
Pre-tax income | -43.0 | -49.6 | -78.2 | -68.6 | -33.4 | -11.3 | -9.0 | -28.7 |
Income taxes | 0.0 | 0.0 | 0.0 | -7.1 | -3.6 | -0.4 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 10.3% | 10.9% | 3.2% | 0.0% | 0.0% |
Net income | -43.0 | -49.6 | -78.2 | -61.5 | -30.8 | -11.0 | -9.2 | -28.7 |
Net margin | | -19305.4% | | | | -2754.3% | -17003.7% | |
|
Basic EPS [+] | ($0.32) | ($0.84) | ($1.95) | ($1.85) | ($1.76) | ($5.62) | ($9.48) | ($0.23) |
Growth | -61.6% | -57.2% | 5.7% | 5.2% | -68.7% | -40.7% | 3942.0% | -16.4% |
Diluted EPS [+] | ($0.32) | ($0.84) | ($1.95) | ($1.85) | ($1.76) | ($5.62) | ($9.48) | ($0.23) |
Growth | -61.6% | -57.2% | 5.7% | 5.2% | -68.7% | -40.7% | 3942.0% | -16.4% |
|
Shares outstanding (basic) [+] | 133.9 | 59.3 | 40.0 | 33.3 | 17.5 | 2.0 | 1.0 | 122.4 |
Growth | 125.8% | 48.2% | 20.2% | 90.1% | 793.7% | 102.4% | -99.2% | 59.8% |
Shares outstanding (diluted) [+] | 133.9 | 59.3 | 40.0 | 33.3 | 17.5 | 2.0 | 1.0 | 122.4 |
Growth | 125.8% | 48.2% | 20.2% | 90.1% | 793.7% | 102.4% | -99.2% | 59.8% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |